Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.99m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Trading Update

19 May 2016 07:00

RNS Number : 6525Y
Science Group PLC
19 May 2016
 

 

19 May 2016

 

 

Science Group plc

(the "Company")

 

 

Trading update

 

Science Group plc provides the following update ahead of the Company's Annual General Meeting this morning.

 

Overall the Group performance in the first 4 months of the year is in line with the Board's expectations. At 30 April 2016, the Group had gross cash of £18.4 million and net funds of £10.9 million.

 

As a science-based services business with limited forward visibility, the Group has seen the benefits from the increase in diversification of client end-markets derived from the acquisition programme. In Q1, the Oil & Gas market continued to be challenging and the Medical business continued to suffer from the lack of new projects to replace those completed in 2015. However, following a change in Group management structure and US sales leadership, a number of significant projects have been won in the Medical sector in recent months which should improve performance in this business for the remainder of the year. The Group's other three business areas have performed satisfactorily, with Leatherhead (food & beverage) outperforming the Board's expectations in terms of profit contribution. As a result, in aggregate, Group revenue and adjusted operating profit to date are in line with the Board's expectations.

 

With a significant proportion of the Group's revenue denominated in US Dollars or Euros, there is an inherent sensitivity within the financial results related to foreign currency exchange fluctuations. While this effect impacts most international companies, IFRS accounting results in Science Group being particularly susceptible due to the majority of the Group's non-Sterling denominated invoices being raised directly from the UK. In brief, IFRS accounting requires that in this operating model, the balance sheet (debtor and WIP) of the relevant operating UK subsidiary is revalued each month with any positive or negative movement being recognised in the Group P&L; in the case where the non-Sterling revenues are invoiced from an in-country subsidiary, such variances would be recognised directly in reserves, although in pre-tax cash terms there is no material difference. This accounting anomaly results in significant additional FX volatility in the reported IFRS Group P&L statement but has the cash benefit of recording profits in the UK (where the work is undertaken) with its lower corporation tax rate. The recent volatility in Sterling-US Dollar exchange rates has brought this issue into sharp focus but the Board considers that the cash benefit to the Group outweighs the non-cash IFRS P&L reporting volatility.

 

The works at Great Burgh, Epsom have now received planning consent and, despite the delays in this process, relocation of the Leatherhead and OTM businesses remains on track to be completed over the summer. Approximately 80 employees are now based at Epsom and feedback from client events held there in recent weeks has been excellent. Following the purchase of the Great Burgh freehold property, the Board has now commenced negotiations regarding the possibility of increasing the Group's banking facilities, such debt to be secured on the Group's substantial freehold property assets which had a carrying value of £20.9 million as at 31 December 2015.

 

- Ends -

 

For further information:

Science Group plc

Martyn Ratcliffe, Chairman

Tel: +44 (0) 1223 875 200

Rebecca Hemsted, Finance Director

 

Numis Securities Limited

Nominated Adviser: Simon Willis / Paul Gillam

Tel: +44 (0) 20 7260 1000

Corporate Broking: Michael Burke

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUWVVRNRAVAAR
Date   Source Headline
2nd Nov 202210:44 amRNSForm 8 (DD) - TP Group plc
2nd Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
1st Nov 202210:33 amRNSRule 2.10 - M&G Letter of Intent
1st Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
31st Oct 20225:41 pmRNSTotal Voting Rights
31st Oct 20225:22 pmRNSForm 8 (OPD) - TP Group plc
31st Oct 20227:00 amRNSRecommended Cash Aquisition of TP Group plc
12th Oct 20224:55 pmRNSTreasury shares issued
30th Sep 20224:35 pmRNSTotal Voting Rights
28th Sep 20227:00 amRNSIssue of share options and PDMR dealing
21st Sep 20223:59 pmRNSTreasury shares issued
2nd Sep 20225:37 pmRNSTransaction in Own Shares
2nd Sep 20227:00 amRNSTransaction in Own Shares
1st Sep 20227:00 amRNSTotal Voting Rights
26th Aug 20225:47 pmRNSTransaction in Own Shares
10th Aug 20227:00 amRNSTransaction in Own Shares
9th Aug 20227:00 amRNSTransaction in Own Shares
2nd Aug 20225:18 pmRNSTransaction in Own Shares
29th Jul 20225:41 pmRNSTransaction in Own Shares
28th Jul 20225:53 pmRNSTransaction in Own Shares
27th Jul 20225:31 pmRNSTransaction in Own Shares
27th Jul 20223:24 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSTransaction in Own Shares
25th Jul 20227:00 amRNSInterim results for 6 months ended 30 June 2022
22nd Jul 20227:00 amRNSNotice of Interim Results
31st May 20224:40 pmRNSTotal Voting Rights
24th May 20225:31 pmRNSTransaction in Own Shares
23rd May 20225:15 pmRNSTransaction in Own Shares
19th May 20225:39 pmRNSHolding(s) in Company
19th May 20225:37 pmRNSHolding(s) in Company
18th May 20225:50 pmRNSTransaction in Own Shares
18th May 20221:17 pmRNSResult of AGM
18th May 20227:00 amRNSAGM Trading Update and NED Appointment
10th May 20224:45 pmRNSTreasury shares issued
29th Apr 20224:45 pmRNSTotal Voting Rights
12th Apr 20227:00 amRNSPosting of AGM documents & Notice of AGM
7th Apr 20227:23 amRNSTransaction in Own Shares
5th Apr 20225:30 pmRNSTransaction in Own Shares
4th Apr 20226:00 pmRNSTransaction in Own Shares
1st Apr 20225:30 pmRNSTransaction in Own Shares
1st Apr 20227:00 amRNSTransaction in Own Shares & Total Voting Rights
30th Mar 20225:20 pmRNSTransaction in Own Shares
29th Mar 20225:30 pmRNSTransaction in Own Shares
28th Mar 20225:10 pmRNSTransaction in Own Shares
25th Mar 20225:15 pmRNSTransaction in Own Shares
25th Mar 20227:00 amRNSTransaction in Own Shares
23rd Mar 20224:55 pmRNSTransaction in Own Shares
22nd Mar 20226:15 pmRNSTransaction in Own Shares
21st Mar 20225:25 pmRNSTransaction in Own Shares
18th Mar 20225:10 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.